Scandinavian Medical Solutions A/S (CPH:SMSMED)

CPH:SMSMED Income Statement

Financials in millions DKK. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Revenue	245.44	226.68	191.19	110.53	71.64
Revenue Growth (YoY)	8.28%	18.56%	72.98%	54.29%	70.78%
Cost of Revenue	211.16	186.58	156.46	87.85	57.76
Gross Profit	34.28	40.1	34.73	22.68	13.88
Selling, General & Admin	23.76	19.09	13.65	7.33	2.98
Other Operating Expenses	0.1	-	-	-	-
Operating Expenses	32.49	26.35	18.1	7.94	3.01
Operating Income	1.79	13.75	16.63	14.74	10.87
Interest Expense	-2.15	-5.23	-0.98	-0.25	-0.54
Interest & Investment Income	0.58	1.55	0.14	0.22	-
Currency Exchange Gain (Loss)	-	-	-	-	0.2
Pretax Income	0.22	10.07	15.79	14.71	10.54
Income Tax Expense	0.19	2.28	3.57	3.34	2.38
Net Income	0.03	7.79	12.22	11.37	8.16
Net Income to Common	0.03	7.79	12.22	11.37	8.16
Net Income Growth	-99.67%	-36.30%	7.49%	39.42%	80.82%
Shares Outstanding (Basic)	28	27	27	27	-
Shares Outstanding (Diluted)	28	27	27	27	-
Shares Change (YoY)	0.67%	0.57%	2.22%	-	-
EPS (Basic)	0.00	0.28	0.45	0.43	-
EPS (Diluted)	0.00	0.28	0.45	0.43	-
EPS Growth	-99.67%	-36.66%	5.15%	-	-
Free Cash Flow	-34.22	-15.08	-49.19	-24.33	4.02
Free Cash Flow Per Share	-1.24	-0.55	-1.80	-0.91	-
Gross Margin	13.97%	17.69%	18.16%	20.52%	19.38%
Operating Margin	0.73%	6.07%	8.70%	13.34%	15.18%
Profit Margin	0.01%	3.44%	6.39%	10.29%	11.39%
Free Cash Flow Margin	-13.94%	-6.65%	-25.73%	-22.01%	5.62%
EBITDA	10.41	21.01	21.08	15.35	10.9
EBITDA Margin	4.24%	9.27%	11.03%	13.89%	15.21%
D&A For EBITDA	8.62	7.26	4.46	0.61	0.02
EBIT	1.79	13.75	16.63	14.74	10.87
EBIT Margin	0.73%	6.07%	8.70%	13.34%	15.18%
Effective Tax Rate	87.91%	22.66%	22.60%	22.70%	22.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.